FAYE M JOHNSON to Antibodies, Monoclonal, Humanized
This is a "connection" page, showing publications FAYE M JOHNSON has written about Antibodies, Monoclonal, Humanized.
Connection Strength
0.032
-
Impact of Neoadjuvant Durvalumab with or without Tremelimumab on CD8+ Tumor Lymphocyte Density, Safety, and Efficacy in Patients with Oropharynx Cancer: CIAO Trial Results. Clin Cancer Res. 2020 07 01; 26(13):3211-3219.
Score: 0.019
-
Combating resistance to anti-IGFR antibody by targeting the integrin ?3-Src pathway. J Natl Cancer Inst. 2013 Oct 16; 105(20):1558-70.
Score: 0.012